Pillar Biosciences said Monday that China's National Medical Products Administration has granted commercial approval for its OncoReveal Dx Colon Cancer Assay.

The Biden administration has been planning for how to get past the crisis phase of the Covid-19 pandemic and will stop buying vaccines, treatments and tests as early as this fall, White House Covid-19 Response Coordinator Dr. Ashish Jha said on Tuesday.

According to reports, Shanghai United Imaging Healthcare Co., Ltd was officially listed on the Science and Technology Innovation Board on August 22 with the stock code "688271".

Researchers at the University of California, Los Angeles have identified noncoding genetic regulatory elements that impact the risk of dementia from Alzheimer's disease and the pathologically related progressive supranuclear palsy (PSP).

As an important medical resource to save lives, blood safety is very important and blood screening is the most critical link to ensure blood safety.

A pair of new studies examines genetic variations that confer risk of developing autism spectrum disorder, providing insight into the different phenotypes associated with the disorder.

San Diego-based diagnostics firm CorDx said on Thursday that it has obtained CE-IVD marks for a PCR test and a lateral flow test for monkeypox.

On August 17, AutoBio Diagnostics released its first-half results of 2022. The company achieved CNY 2.070 billion revenue by the end of June, with a year-on-year increase of 23.41%. The net profit attributable to shareholders was CNY 534 million, increasing 29.28% than the last year.

French diagnostics firm Eurobio Scientific said on Wednesday that it has agreed to acquire Genome Diagnostics, also known as GenDx, for €135 million ($137.2 million) in cash.

Agilent Technologies announced after the close of the market Tuesday that its fiscal third quarter revenues grew 8 percent year over year, topping the consensus Wall Street estimate.

Recently, four products of Tianlong Science and Technology, including E. coli, Salmonella, Staphylococcus aureus, and Listeria monocytogenes DNA detection kits, have obtained EU CE certification.

Illumina and the Minderoo Foundation said on Tuesday that they have signed a partnership to commit A$40 million ($27.8 million) towards sequencing DNA in marine systems.

Ginkgo Bioworks reported after the close of the market on Monday that its second quarter 2022 revenues grew 231 percent year over year, driven by biosecurity service revenues.

August 11, the Second Roche Pan-Tumor Precision Diagnosis and Innovation Ecology Forum was officially opened at Roche Pharma China Shanghai Campus, where participants discussed solutions for pan-tumor precision diagnosis and treatment.

Becton Dickinson announced on Monday that it has inked a deal with Accelerate Diagnostics to sell that firm's Accelerate Pheno system and the Accelerate Arc module for antimicrobial susceptibility testing.